PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of iaiPermissionsJournals.ASM.orgJournalIAI ArticleJournal InfoAuthorsReviewers
 
Infect Immun. 1985 March; 47(3): 774–779.
PMCID: PMC261386

Effects of iron and desferrioxamine on infections with Yersinia enterocolitica.

Abstract

The effects of iron-dextran and the iron chelator desferrioxamine B mesylate (Desferal) on the course and outcome of experimental yersiniosis were investigated. Yersinia enterocolitica strains representing the three leading serogroups pathogenic for humans, O3, O8 and O9, were studied. In mice, iron-dextran reduced the median lethal dose of intraperitoneally administered Y. enterocolitica O3 and O9 ca. 10-fold, whereas Desferal reduced this value more than 100,000-fold. Experiments in which Y. enterocolitica was given orally to mice and intraconjunctivally to guinea pigs confirmed that Desferal markedly increased the susceptibility of animals to yersiniosis. Although serogroup O8 yersiniae were inherently more virulent for laboratory animals, they were less affected by Desferal than were O3 or O9 strains. In vitro experiments indicated that Desferal promoted growth of Y. enterocolitica under iron-limiting conditions and suggested that the enhanced virulence of O8 yersiniae may be due to their comparatively low requirement for iron. The adverse effect of Desferal on the course of experimental infection with Y. enterocolitica may partly explain the heightened susceptibility of iron-overloaded patients to systemic yersiniosis.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.1M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Images in this article

Click on the image to see a larger version.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Aisen P. The binding and release of iron by transferrin. Birth Defects Orig Artic Ser. 1976;12(8):81–95. [PubMed]
  • Bottone EJ. Yersinia enterocolitica: a panoramic view of a charismatic microorganism. CRC Crit Rev Microbiol. 1977;5(2):211–241. [PubMed]
  • Bouza E, Dominguez A, Meseguer M, Buzon L, Boixeda D, Revillo MJ, de Rafael L, Martinez-Beltran J. Yersinia enterocolitica Septicemia. Am J Clin Pathol. 1980 Oct;74(4):404–409. [PubMed]
  • Bullen JJ. The significance of iron in infection. Rev Infect Dis. 1981 Nov-Dec;3(6):1127–1138. [PubMed]
  • Butzler JP, Alexander M, Segers A, Cremer N, Blum D. Enteritis, abscess, and septicemia due to Yersinia enterocolitica in a child with thalassemia. J Pediatr. 1978 Oct;93(4):619–621. [PubMed]
  • Calver GA, Kenny CP, Kushner DJ. Inhibition of the growth of Neisseria meningitidis by reduced ferritin and other iron-binding agents. Infect Immun. 1979 Sep;25(3):880–890. [PMC free article] [PubMed]
  • Finkelstein RA, Sciortino CV, McIntosh MA. Role of iron in microbe-host interactions. Rev Infect Dis. 1983 Sep-Oct;5 (Suppl 4):S759–S777. [PubMed]
  • Finkelstein RA, Yancey RJ. Effect of siderophores on virulence of Neisseria gonorrhoeae. Infect Immun. 1981 May;32(2):609–613. [PMC free article] [PubMed]
  • Graziano JH, Cerami A. Chelation therapy for the treatment of thalassemia. Semin Hematol. 1977 Jan;14(1):127–134. [PubMed]
  • Gutman LT, Ottesen EA, Quan TJ, Noce PS, Katz SL. An inter-familial outbreak of Yersinia enterocolitica enteritis. N Engl J Med. 1973 Jun 28;288(26):1372–1377. [PubMed]
  • Hughes D. Isolation of Yersinia enterocolitica from milk and a dairy farm in Australia. J Appl Bacteriol. 1979 Feb;46(1):125–130. [PubMed]
  • Jones RL, Peterson CM, Grady RW, Kumbaraci T, Cerami A, Graziano JH. Effects of iron chelators and iron overload on Salmonella infection. Nature. 1977 May 5;267(5606):63–65. [PubMed]
  • Keet EE. Yersinia enterocolitica septicemia. Source of infection and incubation period identified. N Y State J Med. 1974 Nov;74(12):2226–2230. [PubMed]
  • Keown P, Descamps-Latscha B. In vitro suppression of cell-mediated immunity by ferroproteins and ferric salts. Cell Immunol. 1983 Sep;80(2):257–266. [PubMed]
  • Khimji PL, Miles AA. Microbial iron-chelators and their action on Klebsiella infections in the skin of guinea-pigs. Br J Exp Pathol. 1978 Apr;59(2):137–147. [PubMed]
  • Lipschitz DA, Dugard J, Simon MO, Bothwell TH, Charlton RW. The site of action of desferrioxamine. Br J Haematol. 1971 Apr;20(4):395–404. [PubMed]
  • Melby K, Slørdahl S, Gutteberg TJ, Nordbø SA. Septicaemia due to Yersinia enterocolitica after oral overdoses of iron. Br Med J (Clin Res Ed) 1982 Aug 14;285(6340):467–468. [PMC free article] [PubMed]
  • Modell B. Advances in the use of iron-chelating agents for the treatment of iron overload. Prog Hematol. 1979;11:267–312. [PubMed]
  • Neilands JB. Microbial iron compounds. Annu Rev Biochem. 1981;50:715–731. [PubMed]
  • Perry RD, Brubaker RR. Accumulation of iron by yersiniae. J Bacteriol. 1979 Mar;137(3):1290–1298. [PMC free article] [PubMed]
  • Portnoy DA, Wolf-Watz H, Bolin I, Beeder AB, Falkow S. Characterization of common virulence plasmids in Yersinia species and their role in the expression of outer membrane proteins. Infect Immun. 1984 Jan;43(1):108–114. [PMC free article] [PubMed]
  • Rabson AR, Hallett AF, Koornhof HJ. Generalized Yersinia enterocolitica infection. J Infect Dis. 1975 Apr;131(4):447–451. [PubMed]
  • Robins-Browne RM, Rabson AR, Koornhof HJ. Generalized infection with Yersinia enterocolitica and the role of iron. Contrib Microbiol Immunol. 1979;5:277–282. [PubMed]
  • Roche G, Leheup B, Gérard A, Canton P, Lion C, Leichtmann G, Dureux JB. Septicémies à Yersinia enterocolitica. Revue générale à propos d'un nouvaeu cas chez une jeune femme présentant une thalassémie majeure. Rev Med Interne. 1982 Mar;3(1):65–74. [PubMed]
  • Rogers HJ. Iron-Binding Catechols and Virulence in Escherichia coli. Infect Immun. 1973 Mar;7(3):445–456. [PMC free article] [PubMed]
  • Smith RE, Carey AM, Damare JM, Hetrick FM, Johnston RW, Lee WH. Evaluation of iron dextran and mucin for enhancement of the virulence of Yersinia enterocolitica serotype O:3 in mice. Infect Immun. 1981 Nov;34(2):550–560. [PMC free article] [PubMed]
  • Sword CP. Mechanisms of pathogenesis in Listeria monocytogenes infection. I. Influence of iron. J Bacteriol. 1966 Sep;92(3):536–542. [PMC free article] [PubMed]
  • Weinberg ED. Iron and infection. Microbiol Rev. 1978 Mar;42(1):45–66. [PMC free article] [PubMed]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)